Jiangsu Jibeier Pharmaceutical Co Ltd (688566) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.07 Million ≈ $1.62 Million USD) by net assets (CN¥2.37 Billion ≈ $346.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jiangsu Jibeier Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688566 liabilities breakdown for a breakdown of total debt and financial obligations.

Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MLP SE XETRA:MLP	-0.009x
BANPU POWER BK:BPP-R	-0.005x
Banco Mercantil do Brasil S.A SA:BMEB3	0.013x
PPHE Hotel Group Ltd F:32P	0.024x
Aeva Technologies, Inc. Common Stock NASDAQ:AEVA	-1.676x
Lotus Technology Inc. NASDAQ:LOT	0.672x
Indus Holding AG XETRA:INH	0.106x
Shenzhen Prince New Materials Co Ltd SHE:002735	0.019x

Annual Cash Flow Conversion Efficiency for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Jibeier Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.25 Billion ≈ $329.81 Million	CN¥215.29 Million ≈ $31.50 Million	0.096x	+14.41%
2023-12-31	CN¥1.91 Billion ≈ $279.55 Million	CN¥159.50 Million ≈ $23.34 Million	0.083x	-6.15%
2022-12-31	CN¥1.69 Billion ≈ $247.93 Million	CN¥150.72 Million ≈ $22.06 Million	0.089x	-4.97%
2021-12-31	CN¥1.61 Billion ≈ $235.34 Million	CN¥150.56 Million ≈ $22.03 Million	0.094x	+25.73%
2020-12-31	CN¥1.58 Billion ≈ $230.67 Million	CN¥117.36 Million ≈ $17.17 Million	0.074x	-69.66%
2019-12-31	CN¥470.46 Million ≈ $68.84 Million	CN¥115.45 Million ≈ $16.89 Million	0.245x	-10.41%
2018-12-31	CN¥357.68 Million ≈ $52.34 Million	CN¥97.97 Million ≈ $14.34 Million	0.274x	+8.12%
2017-12-31	CN¥440.76 Million ≈ $64.50 Million	CN¥111.66 Million ≈ $16.34 Million	0.253x	+134.16%
2016-12-31	CN¥363.15 Million ≈ $53.14 Million	CN¥39.29 Million ≈ $5.75 Million	0.108x	--

About Jiangsu Jibeier Pharmaceutical Co Ltd

SHG:688566 China Drug Manufacturers - Specialty & Generic

Market Cap

$821.50 Million

CN¥5.61 Billion CNY

Market Cap Rank

#10084 Global

#2878 in China

Share Price

CN¥28.15

Change (1 day)

+0.54%

52-Week Range

CN¥24.05 - CN¥42.20

All Time High

CN¥51.60